CorMedix, Inc. (CRMD)
4.82
+0.16
(+3.43%)
USD |
NASDAQ |
Nov 16, 16:00
4.82
0.00 (0.00%)
After-Hours: 07:16
CorMedix Net Income (Quarterly) : -14.72M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -14.72M |
| June 30, 2026 | 25.99M |
| March 31, 2026 | 38.60M |
| December 31, 2025 | 14.02M |
| September 30, 2025 | 108.56M |
| June 30, 2025 | 19.83M |
| March 31, 2025 | 20.64M |
| December 31, 2024 | 13.46M |
| September 30, 2024 | -2.777M |
| June 30, 2024 | -14.15M |
| March 31, 2024 | -14.47M |
| December 31, 2023 | -14.75M |
| September 30, 2023 | -9.744M |
| June 30, 2023 | -11.27M |
| March 31, 2023 | -10.57M |
| December 31, 2022 | -8.209M |
| September 30, 2022 | -6.854M |
| June 30, 2022 | -7.605M |
| March 31, 2022 | -7.034M |
| December 31, 2021 | -7.791M |
| September 30, 2021 | -8.569M |
| June 30, 2021 | -4.633M |
| March 31, 2021 | -7.217M |
| December 31, 2020 | -6.087M |
| September 30, 2020 | -6.601M |
| Date | Value |
|---|---|
| June 30, 2020 | -3.782M |
| March 31, 2020 | -5.558M |
| December 31, 2019 | -5.304M |
| September 30, 2019 | -5.265M |
| June 30, 2019 | -0.6962M |
| March 31, 2019 | -5.168M |
| December 31, 2018 | 2.148M |
| September 30, 2018 | -10.24M |
| June 30, 2018 | -8.557M |
| March 31, 2018 | -10.19M |
| December 31, 2017 | -10.31M |
| September 30, 2017 | -9.956M |
| June 30, 2017 | -5.146M |
| March 31, 2017 | -7.597M |
| December 31, 2016 | -6.399M |
| September 30, 2016 | -9.126M |
| June 30, 2016 | -4.887M |
| March 31, 2016 | -4.118M |
| December 31, 2015 | -3.866M |
| September 30, 2015 | -4.688M |
| June 30, 2015 | -4.135M |
| March 31, 2015 | -5.498M |
| December 31, 2014 | -2.214M |
| September 30, 2014 | -5.035M |
| June 30, 2014 | 2.743M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -10.73M |
| Eloxx Pharmaceuticals, Inc. | -5.543M |
| Breakthrough Chemistry, Inc. | -1.083M |
| BioStem Technologies, Inc. | -11.38M |
| Cardiac Biotech Solutions, Inc. | -0.1372M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 54.52M |
| Total Expenses (Quarterly) | 69.24M |
| EPS Diluted (Quarterly) | -0.1877 |
| Enterprise Value | 172.70M |
| Gross Profit Margin (Quarterly) | 55.03% |
| Profit Margin (Quarterly) | -27.00% |
| Earnings Yield | 13.65% |
| Operating Earnings Yield | 36.89% |
| Normalized Earnings Yield | 17.70 |